Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?

T1 bladder cancer constitutes approximately 25% of incident bladder cancers, and as such carries an important public health impact. Notably, it has a heterogeneous natural history, with large variation in reported oncologic outcomes. Optimal risk-stratification is essential to individualize patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Gershman, Boris, Boorjian, Stephen A., Hautmann, Richard E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927848/
https://www.ncbi.nlm.nih.gov/pubmed/27376120
http://dx.doi.org/10.3233/BLC-150022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927848/
https://www.ncbi.nlm.nih.gov/pubmed/27376120
http://dx.doi.org/10.3233/BLC-150022

Ejemplares similares